Co-Diagnostics reported a gross margin of 72.73% and a net margin of -3,782.43% for the quarter ended Jun 2026. These financial ratios cover 39 quarters of results from Jun 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2016 | Sep2016 | Dec2016 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||
| Gross Margin | 90.85% | 89.00% | 87.81% | 85.54% | 81.78% | 84.93% | 63.20% | 16.57% | -132.09% | 89.59% | 16.52% | 49.88% | 92.02% | 53.61% | -70.81% | 57.06% | 80.29% | 81.92% | 46.05% | 72.73% | |||||||||||||||||||
| EBT Margin | 43.61% | 45.10% | 50.21% | 57.71% | -68.24% | -68.23% | -1,786.99% | -1,331.52% | -5,640.45% | -329.49% | -304.98% | -1,985.51% | -285.25% | -1,508.91% | -7,392.85% | -14,959.66% | -4,737.46% | -4,851.71% | -9,934.54% | -3,770.89% | |||||||||||||||||||
| EBIT Margin | 43.10% | 45.28% | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -3,732.47% | |||||||||||||||||||
| EBITDA Margin | 43.36% | 45.59% | 51.03% | 44.37% | -74.11% | -122.15% | -1,842.53% | -1,600.55% | -5,909.42% | -351.62% | -323.82% | -2,122.20% | -276.33% | -1,541.58% | -7,734.74% | -16,451.88% | -4,767.26% | -4,640.57% | -9,955.30% | -3,610.97% | |||||||||||||||||||
| Operating Margin | 43.10% | 45.28% | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -3,732.47% | |||||||||||||||||||
| Net Margin | 35.77% | 38.12% | 36.75% | 51.61% | -53.48% | -26.72% | -1,563.02% | -956.11% | -4,508.87% | -243.47% | -412.82% | -1,990.37% | -286.03% | -1,512.37% | -7,387.37% | -14,983.53% | -4,745.02% | -4,049.27% | -9,755.05% | -3,782.43% | |||||||||||||||||||
| FCF Margin | 44.53% | 37.68% | 23.32% | 32.64% | 22.83% | 17.44% | -307.04% | -1,012.94% | -3,086.23% | -244.26% | -147.48% | -1,900.73% | -199.59% | -1,154.81% | -5,561.02% | -17,576.88% | -5,333.55% | -4,113.14% | -2,398.92% | ||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||
| Assets AverageAssets Avg. | 0.09B | 0.10B | 0.13B | 0.17B | 0.17B | 0.15B | 0.14B | 0.12B | 0.11B | 0.11B | 0.10B | 0.09B | 0.08B | 0.08B | 0.07B | 0.06B | 0.05B | 0.05B | 0.03B | 0.02B | |||||||||||||||||||
| Equity AverageEquity Avg. | 0.08B | 0.09B | 0.12B | 0.14B | 0.15B | 0.14B | 0.12B | 0.11B | 0.11B | 0.10B | 0.09B | 0.08B | 0.08B | 0.07B | 0.06B | 0.05B | 0.04B | 0.04B | 0.03B | 0.02B | |||||||||||||||||||
| Invested CapitalInvested Cap. | |||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 1.11 | 1.06 | 0.74 | 0.61 | 0.47 | 0.34 | 0.25 | 0.10 | 0.06 | 0.04 | 0.07 | 0.07 | 0.11 | 0.10 | 0.06 | 0.06 | 0.02 | 0.01 | 0.02 | 0.04 | |||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | |||||||||||||||||||||||||||||||||||||||
| Debt Ratio | |||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | |||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 154.69 | 200.98 | 247.15 | 155.69 | 203.03 | 196.32 | |||||||||||||||||||||||||||||||||
| Price to SalesP/S | 74.21 | 80.61 | 92.56 | 62.66 | 72.68 | 55.95 | 68.21 | 112.21 | 140.53 | 209.29 | 183.10 | 157.38 | 130.97 | 163.55 | 189.96 | 89.64 | 322.42 | 769.92 | 10.83 | 18.10 | |||||||||||||||||||
| Price to BookP/B | 81.94 | 84.21 | 67.38 | 42.66 | 39.35 | 22.06 | 20.38 | 12.29 | 9.91 | 9.80 | 14.57 | 13.41 | 16.53 | 18.77 | 13.80 | 6.60 | 7.95 | 9.82 | 0.33 | 1.05 | |||||||||||||||||||
| Enterprise Value | 7.08B | 8.35B | 8.97B | 6.20B | 5.59B | 2.89B | 2.25B | 1.28B | 0.96B | 0.91B | 1.19B | 1.00B | 1.15B | 1.16B | 0.71B | 0.29B | 0.31B | 0.38B | -0.01B | 0.01B | |||||||||||||||||||
| EV to EBIT | 141.01 | 161.25 | 194.74 | 136.19 | 188.73 | 305.91 | |||||||||||||||||||||||||||||||||
| EV to EBITDA | 140.36 | 160.35 | 193.33 | 134.66 | 183.35 | 274.36 | |||||||||||||||||||||||||||||||||
| Market Capitalization | 7.15B | 8.43B | 9.06B | 6.30B | 5.69B | 2.98B | 2.33B | 1.36B | 1.03B | 0.97B | 1.25B | 1.05B | 1.20B | 1.20B | 0.74B | 0.31B | 0.32B | 0.39B | 0.01B | 0.01B | |||||||||||||||||||
| Price to FCFP/FCF | 136.83 | 152.95 | 224.20 | 176.55 | 230.59 | 209.66 | 453.97 | ||||||||||||||||||||||||||||||||
| EV to FCF | 135.44 | 151.43 | 221.98 | 173.82 | 226.69 | 203.57 | 438.17 | ||||||||||||||||||||||||||||||||
| EV to CFO | 133.02 | 148.69 | 218.36 | 169.43 | 216.24 | 187.03 | 342.94 | ||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 43.10% | 45.28% | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -3,732.47% | |||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 61.04% | 54.54% | 38.36% | 29.86% | 18.59% | 6.37% | -20.50% | -40.16% | -49.74% | -53.96% | -44.37% | -50.18% | -49.37% | -56.54% | -66.08% | -71.09% | -82.28% | -84.78% | -160.78% | -268.57% | |||||||||||||||||||
| Return on Assets [ROA]ROA | 53.16% | 42.36% | 27.63% | 24.44% | 16.87% | 9.83% | -10.51% | -26.41% | -33.02% | -38.43% | -34.64% | -42.74% | -44.89% | -53.94% | -55.37% | -60.42% | -70.84% | -70.57% | -134.98% | -220.87% | |||||||||||||||||||
| Return on Equity [ROE]ROE | 56.53% | 44.78% | 31.25% | 28.69% | 19.17% | 10.86% | -11.42% | -28.17% | -35.45% | -41.95% | -38.18% | -47.45% | -49.84% | -60.63% | -63.98% | -70.76% | -81.63% | -79.92% | -155.14% | -273.82% |
Pull Co-Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CODX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CODX", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CODX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();